Does Meal “Dose” Matter in Heart Failure? The MEDIMEALS Trial (7 vs 21 Meals/Week)
Prado Content team
October 9, 2023
A randomized crossover trial in post-discharge heart failure found that medically tailored meals improved malnutrition risk, American Heart Association (AHA) diet adherence, and sarcopenia risk — with 7 versus 21 meals per week delivering similar benefits.
.jpg)
Quick take for clinicians: In the MEDIMEALS crossover trial, heart failure patients at malnutrition risk received either 7 or 21 home-delivered medically tailored meals per week after discharge.
The study primarily assessed nutritional status improvements; early reports also suggest readmissions were below local/national averages during program periods, warranting larger effectiveness trials.
Sources: BMC Nutrition; trial registry; institutional news release.
Study Design at a Glance
- Population: Adults with heart failure at malnutrition risk or with malnutrition, immediately post-hospital discharge.
- Design: Random-order crossover feeding trial comparing 7 vs 21 meals/week; each participant experienced both “doses.”
- Intervention: Heart-healthy, protein-adequate, sodium-conscious meals delivered to the home.
- Primary outcomes: Nutritional metrics (e.g., malnutrition risk scores, weight stability); secondary signals for care utilization.
- Registration & publication: NCT06142903; peer-reviewed in BMC Nutrition (2025).
Key Findings
- Nutritional status improved during MTM support, with indications that the higher “dose” may better sustain calorie/protein adequacy for some patients.
- Readmission signal: Institutional reporting noted readmissions were below local and national averages during program windows (exploratory, non-comparative).
- Feasibility & adherence: Home delivery plus clear sodium/protein targets supported adherence in the early post-discharge period.
How to Act on This Evidence
A Pragmatic “Dose” Pathway for HF Discharges
- Identify HF patients with malnutrition risk (e.g., screening scores, recent weight loss) or IADL limitations.
- Start with 7–14 meals/week for 4–8 weeks if budget-constrained; consider 21/week in the highest-risk patients to lock in nutrition early.
- Pair with RD telehealth to titrate sodium, protein, fluid guidance, and troubleshoot barriers.
- Track outcomes: 30- and 90-day readmissions, ED visits, weight, malnutrition scores, patient-reported energy/function.
Operational & Payer Considerations
- Workflow: Add MTM referral prompts to HF discharge order sets; pre-schedule RD follow-ups.
- Coverage: Clarify payer policies, use HSA/FSA where applicable; align with value-based HF programs.
- Logistics: Ensure delivery reliability and cold-chain integrity; measure patient satisfaction with menu fit and timing.
Fast onboarding • Evidence-aligned menus • Outcome tracking
FAQs
Who is the ideal candidate after HF discharge?
Patients with documented malnutrition risk, recent weight loss, or functional barriers to cooking/shopping—especially within 30 days of hospitalization.
How many meals per week should we prescribe?
Start with 7–14 meals/week for most; consider 21/week for high-risk patients needing full meal coverage during the vulnerable post-discharge window.
Which outcomes should we monitor?
Malnutrition risk scores, weight stability, 30/90-day readmissions and ED visits, and patient-reported energy and diet adherence.
Bring MTMs into Your Heart Failure Discharge Plan
Prado streamlines prescribing heart-healthy, medically tailored meals with HSA/FSA rails, dietitian touchpoints, and outcomes tracking—built for value-based HF care.

Prado Content team
The Prado Content Team is made up of food-for-health experts, clinicians, and nutrition specialists who create trusted, evidence-based content on Food as Medicine and preventive care.
Related articles
.jpg)
Across 49 States, Medically Tailored Meals Could Save Millions: State-Level Modeling
Health Affairs: MTMs could save costs in nearly every state—implications for healthcare providers, payers, and policymakers.
Read more.jpg)
Beyond GLP-1s: How Food-as-Medicine Can Improve Outcomes and Bend the Cost Curve
GLP-1s deliver strong outcomes, but high costs; pairing with MTMs can sustain results, improve adherence, and control spend.
Read more.jpg)
Evidence Check: What 14 Randomized Trials Really Say About “Food as Medicine”
14 U.S. trials show Food-as-Medicine—what works, what’s promising, and prescribing guidance.
Read more.jpg)
Heart Failure Care at Home: What Medically Tailored Meals Really Deliver
Systematic review shows MTMs may reduce HF readmissions and improve nutrition—what clinicians should do now.
Read more